Skip to Content

Notice

Disease, Disability, and Injury Prevention and Control Special Interest Project (SIP): Initial Review

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble Start Printed Page 28437

The meeting announced below concerns “Case Control Study of Chlamydia and Infertility among Women Assessed for Tubal Disease or Treated by Assisted Reproductive Technology, SIP11-048, Panel F,” initial review

In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting:

Time and Date: 11 a.m.-5 p.m., June 22, 2011 (Closed).

Place: Teleconference.

Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463.

Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of “Case Control Study of Chlamydia and Infertility among Women Assessed for Tubal Disease or Treated by Assisted Reproductive Technology, SIP11-048, Panel F,” initial review.

Contact Person for More Information: Brenda Colley Gilbert, PhD, MPH, Director, Extramural Research Program Office, National Center for Chronic Disease Prevention and Health Promotion, CDC, 4770 Buford Highway, NE., Mailstop K-92, BJC4@cdc.gov.

The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.

Start Signature

Dated: May 5, 2011.

Elaine L. Baker,

Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.

End Signature End Preamble

[FR Doc. 2011-12075 Filed 5-16-11; 8:45 am]

BILLING CODE 4163-18-P